37 filings
8-K
APTO
Aptose Biosciences Inc
19 Dec 19
Aptose Announces Closing of Public Offering of Common Shares
4:02pm
8-K
APTO
Aptose Biosciences Inc
17 Dec 19
Aptose Announces Pricing of Public Offering of Common Shares
2:27pm
8-K
APTO
Aptose Biosciences Inc
16 Dec 19
Aptose Announces Proposed Public Offering of Common Shares
5:30pm
8-K
APTO
Aptose Biosciences Inc
9 Dec 19
Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting
11:00am
8-K
APTO
Aptose Biosciences Inc
9 Dec 19
Aptose Presents Highlights From Corporate Event At ASH
7:00am
8-K
jtp 3jhqtgeau
5 Dec 19
Aptose Appoints Rafael Bejar, M.D., Ph.D., as Chief Medical Officer
2:25pm
8-K
zhle jnat
6 Nov 19
Aptose to Present New CG-806 Data at the 2019 ASH Annual Meeting
10:07am
8-K
8ph9c
5 Nov 19
Results of Operations and Financial Condition
4:02pm
8-K
sqjojv1
22 Oct 19
Results of Operations and Financial Condition
7:05am
8-K
wdp48vv3tpklq 7oq8c2
10 Oct 19
Results of Operations and Financial Condition
7:30am
8-K
e5dew0pcb
6 Aug 19
Conference Call and Webcast at 5pm EDT Today
4:04pm
8-K
zcwxnzsz197t95l775kc
16 Jul 19
Other Events
7:05am
8-K
v81 7isnqx8
14 Jun 19
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association
7:00am
8-K
tzngik9
5 Jun 19
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
12:00am
8-K
560r djxswkf
3 Jun 19
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
5:28pm
8-K
htrhch
3 Jun 19
Aptose Announces Closing of Public Offering of Common Shares
9:04am
8-K
593kg6 yw6eshpqa93
3 Jun 19
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
9:00am
8-K
k4xrb4 g4
30 May 19
Aptose Announces Pricing of Public Offering of Common Shares
4:13pm
8-K
bpz9q2wlzcs
30 May 19
Aptose Announces Pricing of Public Offering of Common Shares
9:29am
8-K
izsx yqn1j
29 May 19
Aptose Announces Proposed Public Offering of Common Shares
4:33pm